Avidity of CD8 T cells sharpens immunodominance

被引:30
作者
Dzutsev, Amiran H.
Belyakov, Igor M. [1 ]
Isakov, Dmitry V.
Margulies, David H.
Berzofsky, Jay A.
机构
[1] NCI, Vaccine Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
关键词
immunodominance; cytotoxic; T lymphocytes; avidity; epitope;
D O I
10.1093/intimm/dxm016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the course of viral infection, the immune system exploits only a fraction of the available CTL repertoire and focuses on a few of a myriad of potentially antigenic peptides. This phenomenon, known as immunodominance, depends on a number of factors, including antigen processing and transport, MHC binding, competition for antigen-presenting cells, availability of the CD8 T cell repertoire and other mechanisms that function largely by restricting the immune response. Here we elucidate a novel mechanism that increases the immunodominance of the epitope rather by enhancing the immune response. Using a peptide-specific MHC-restricted mAb and functional assays of CTL activation, we show that T cells with high avidity for the immunodominant, H-2D(d) restricted, P18-I10 epitope expand rapidly following immunization, and this expansion in turn determines the level of the P18-I10 epitope immunodominance. This proliferation has little dependence on the number of MHC-peptide complexes. Since most self-reactive T cells of high avidity are depleted in the thymus, the selection of immunodominant epitopes based on the expansion of high-avidity T cells in the periphery reduces the potential for autoimmunity.
引用
收藏
页码:497 / 507
页数:11
相关论文
共 55 条
[1]   MECHANISMS INFLUENCING THE IMMUNODOMINANCE OF T-CELL DETERMINANTS [J].
ADORINI, L ;
APPELLA, E ;
DORIA, G ;
NAGY, ZA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (06) :2091-2104
[2]   Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy [J].
AlexanderMiller, MA ;
Leggatt, GR ;
Berzofsky, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) :4102-4107
[3]   Impact of vaccine-induced mucosal high-avidity CD8+CTLs in delay of AIDS viral dissemination from mucosa [J].
Belyakov, IM ;
Kuznetsov, VA ;
Kelsall, B ;
Klinman, D ;
Moniuszko, M ;
Lemon, M ;
Markham, PD ;
Pal, R ;
Clements, JD ;
Lewis, MG ;
Strober, W ;
Franchini, GA ;
Berzofsky, JA .
BLOOD, 2006, 107 (08) :3258-3264
[4]   Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses [J].
Belyakov, IM ;
Earl, P ;
Dzutsev, A ;
Kuznetsov, VA ;
Lemon, M ;
Wyatt, LS ;
Snyder, JT ;
Ahlers, JD ;
Franchini, G ;
Moss, B ;
Berzofsky, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (16) :9458-9463
[5]  
Belyakov IM, 2001, EUR J IMMUNOL, V31, P3557, DOI 10.1002/1521-4141(200112)31:12<3557::AID-IMMU3557>3.0.CO
[6]  
2-O
[7]   Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses [J].
Belz, GT ;
Stevenson, PG ;
Doherty, PC .
JOURNAL OF IMMUNOLOGY, 2000, 165 (05) :2404-2409
[8]   Progress on new vaccine strategies against chronic viral infections [J].
Berzofsky, JA ;
Ahlers, JD ;
Janik, J ;
Morris, J ;
Oh, S ;
Terabe, M ;
Belyakov, IM .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (04) :450-462
[9]   IMMUNODOMINANCE IN LYMPHOCYTE-T RECOGNITION [J].
BERZOFSKY, JA .
IMMUNOLOGY LETTERS, 1988, 18 (02) :83-92
[10]   Progress on new vaccine strategies for the immunotherapy and prevention of cancer [J].
Berzofsky, JA ;
Terabe, M ;
Oh, SK ;
Belyakov, IM ;
Ahlers, JD ;
Janik, JE ;
Morris, JC .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (11) :1515-1525